BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31621585)

  • 1. Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma.
    Thomson BR; Carota IA; Souma T; Soman S; Vestweber D; Quaggin SE
    Elife; 2019 Oct; 8():. PubMed ID: 31621585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-1 is required for Schlemm's canal development in mice and humans.
    Thomson BR; Souma T; Tompson SW; Onay T; Kizhatil K; Siggs OM; Feng L; Whisenhunt KN; Yanovitch TL; Kalaydjieva L; Azmanov DN; Finzi S; Tanna CE; Hewitt AW; Mackey DA; Bradfield YS; Souzeau E; Javadiyan S; Wiggs JL; Pasutto F; Liu X; John SW; Craig JE; Jin J; Young TL; Quaggin SE
    J Clin Invest; 2017 Dec; 127(12):4421-4436. PubMed ID: 29106382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure.
    Li G; Nottebaum AF; Brigell M; Navarro ID; Ipe U; Mishra S; Gomez-Caraballo M; Schmitt H; Soldo B; Pakola S; Withers B; Peters KG; Vestweber D; Stamer WD
    Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):12. PubMed ID: 33315051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.
    Souma T; Tompson SW; Thomson BR; Siggs OM; Kizhatil K; Yamaguchi S; Feng L; Limviphuvadh V; Whisenhunt KN; Maurer-Stroh S; Yanovitch TL; Kalaydjieva L; Azmanov DN; Finzi S; Mauri L; Javadiyan S; Souzeau E; Zhou T; Hewitt AW; Kloss B; Burdon KP; Mackey DA; Allen KF; Ruddle JB; Lim SH; Rozen S; Tran-Viet KN; Liu X; John S; Wiggs JL; Pasutto F; Craig JE; Jin J; Quaggin SE; Young TL
    J Clin Invest; 2016 Jul; 126(7):2575-87. PubMed ID: 27270174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies.
    Thomson BR; Liu P; Onay T; Du J; Tompson SW; Misener S; Purohit RR; Young TL; Jin J; Quaggin SE
    Nat Commun; 2021 Oct; 12(1):6072. PubMed ID: 34663817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lymphatic defect causes ocular hypertension and glaucoma in mice.
    Thomson BR; Heinen S; Jeansson M; Ghosh AK; Fatima A; Sung HK; Onay T; Chen H; Yamaguchi S; Economides AN; Flenniken A; Gale NW; Hong YK; Fawzi A; Liu X; Kume T; Quaggin SE
    J Clin Invest; 2014 Oct; 124(10):4320-4. PubMed ID: 25202984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-1 Knockout Mice as a Genetic Model of Open-Angle Glaucoma.
    Thomson BR; Grannonico M; Liu F; Liu M; Mendapara P; Xu Y; Liu X; Quaggin SE
    Transl Vis Sci Technol; 2020 Mar; 9(4):16. PubMed ID: 32818103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of FOXC2 in the trabecular meshwork and Schlemm's canal in glaucomatous pathology.
    Ujiie N; Norden PR; Fang R; Beckmann L; Cai Z; Kweon J; Liu T; Tan C; Kuhn MS; Stamer WD; Aoto K; Quaggin SE; Zhang HF; Kume T
    Life Sci Alliance; 2023 Sep; 6(9):. PubMed ID: 37414529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of Angiopoietin-2 and Angiopoietin-4 in Schlemm's Canal Maintenance.
    Kapiainen E; Elamaa H; Miinalainen I; Izzi V; Eklund L
    Invest Ophthalmol Vis Sci; 2022 Oct; 63(11):1. PubMed ID: 36190459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Angiopoietin-Tie2 Signaling Protects the Kidney from Ischemic Injury by Modulation of Endothelial-Specific Pathways.
    Li Y; Liu P; Zhou Y; Maekawa H; Silva JB; Ansari MJ; Boubes K; Alia Y; Deb DK; Thomson BR; Jin J; Quaggin SE
    J Am Soc Nephrol; 2023 Jun; 34(6):969-987. PubMed ID: 36787763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma.
    Kim J; Park DY; Bae H; Park DY; Kim D; Lee CK; Song S; Chung TY; Lim DH; Kubota Y; Hong YK; He Y; Augustin HG; Oliver G; Koh GY
    J Clin Invest; 2017 Oct; 127(10):3877-3896. PubMed ID: 28920924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanylate cyclase activators, cell volume changes and IOP reduction.
    Ellis DZ
    Cell Physiol Biochem; 2011; 28(6):1145-54. PubMed ID: 22179003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased outflow facility and Schlemm's canal defects in a mouse model of glaucoma.
    Mavlyutov TA; Kuhn MS; Bilal SE; De Ieso ML; Chauhan AK; Stamer WD; McDowell CM
    Exp Eye Res; 2022 Dec; 225():109249. PubMed ID: 36152913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All TIEd up: mechanisms of Schlemm's canal maintenance.
    Bernier-Latmani J; Petrova TV
    J Clin Invest; 2017 Oct; 127(10):3594-3597. PubMed ID: 28920923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic Consequences of Caveolin-1 Ablation in Conventional Outflow Endothelia.
    De Ieso ML; Gurley JM; McClellan ME; Gu X; Navarro I; Li G; Gomez-Caraballo M; Enyong E; Stamer WD; Elliott MH
    Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):32. PubMed ID: 32940661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of intraocular pressure by microRNA cluster miR-143/145.
    Li X; Zhao F; Xin M; Li G; Luna C; Li G; Zhou Q; He Y; Yu B; Olson E; Gonzalez P; Wang S
    Sci Rep; 2017 Apr; 7(1):915. PubMed ID: 28424493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.
    Rao PV; Pattabiraman PP; Kopczynski C
    Exp Eye Res; 2017 May; 158():23-32. PubMed ID: 27593914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma.
    Young TL; Whisenhunt KN; Jin J; LaMartina SM; Martin SM; Souma T; Limviphuvadh V; Suri F; Souzeau E; Zhang X; Dan Y; Anagnos E; Carmona S; Jody NM; Stangel N; Higuchi EC; Huang SJ; Siggs OM; Simões MJ; Lawson BM; Martin JS; Elahi E; Narooie-Nejad M; Motlagh BF; Quaggin SE; Potter HD; Silva ED; Craig JE; Egas C; Maroofian R; Maurer-Stroh S; Bradfield YS; Tompson SW
    Invest Ophthalmol Vis Sci; 2020 Oct; 61(12):6. PubMed ID: 33027505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1 modulates intraocular pressure: implications for caveolae mechanoprotection in glaucoma.
    Elliott MH; Ashpole NE; Gu X; Herrnberger L; McClellan ME; Griffith GL; Reagan AM; Boyce TM; Tanito M; Tamm ER; Stamer WD
    Sci Rep; 2016 Nov; 6():37127. PubMed ID: 27841369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model.
    Li G; Lee C; Agrahari V; Wang K; Navarro I; Sherwood JM; Crews K; Farsiu S; Gonzalez P; Lin CW; Mitra AK; Ethier CR; Stamer WD
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1714-1722. PubMed ID: 30651311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.